Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zur Rose Group

Explore full profile

European online pharmacy and digital health ecosystem.

Frauenfeld, SwitzerlandFounded 1993Biotech & Life Sciences
Valuation $716M Market cap · 2026
Revenue $1–5B Latest reported FY

About Zur Rose Group

DocMorris AG, formerly known as Zur Rose Group AG, is a Swiss-based company that has evolved into a prominent online pharmacy and digital health provider focused on European markets. Founded in 1993 by Walter Oberhänsli and a group of doctors, the company initially operated as a wholesale supplier for physicians in Switzerland before expanding into the online pharmacy business. A pivotal moment in the company's history occurred in May 2023, when it completed the sale of its original Swiss business to Medbase, a subsidiary of the Migros Group. This strategic transaction marked a fundamental shift in focus towards its business-to-consumer (B2C) operations in Germany and other European countries. Following the sale, the company was renamed DocMorris AG to align with its most recognized brand, though its headquarters and stock exchange listing remain in Switzerland. The company's business model centers on its digital health ecosystem. It operates Germany's largest e-commerce pharmacy, DocMorris, offering a wide range of prescription (Rx) and over-the-counter (OTC) medications, as well as beauty and personal care products. A key strategic focus is capitalizing on the rollout of the electronic prescription (eRx) in Germany, a market valued at over €50 billion. The business is supported by a highly automated logistics center in Heerlen, the Netherlands, capable of handling 27 million parcels annually. In addition to its core pharmacy operations, DocMorris AG has expanded its services through strategic acquisitions, including TeleClinic, a leading telemedicine provider in Germany, and PromoFarma, a health and beauty marketplace in Southern Europe. DocMorris aims to create an integrated platform that connects patients, doctors, and pharmacies, offering services from telehealth consultations to medication delivery. The company is leveraging technology and artificial intelligence to enhance operational efficiency and personalize the customer experience, with the vision of enabling users to manage their health with a single click.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1993
Headquarters
Frauenfeld, Switzerland
Listing
IPO 2017
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇨🇭 Switzerland97.7%
🇩🇪 Germany0.8%
🇸🇬 Singapore0.8%
🇫🇷 France0.8%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zur Rose Group on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zur Rose Group on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.